RWC-340B Objects to Eli Lilly’s Claims Submission Mandate as Unprecedented, Violation of Federal Law

03/09/2026 – RWC-340B Objects to Eli Lilly’s Claims Submission Mandate as Unprecedented, Violation of Federal Law RWC-340B sent a letter to Eli Lilly’s CEO on February 18, 2026, objecting to…

Novo Nordisk Announces Covered Entities Must Submit Claims Data for All of Its Products

3/6/2026 – Novo Nordisk Announces Covered Entities Must Submit Claims Data for All of Its Products Pharmaceutical manufacturer Novo Nordisk (Novo) announced in a notice that, effective April 1, all covered…

HRSA Publishes Notice Contemplating Expanding 340B Rebate Model to 13 Manufacturers and Extends Rebate RFI Comment Deadline

2/27/2026 – HRSA Publishes Notice Contemplating Expanding 340B Rebate Model to 13 Manufacturers and Extends Rebate RFI Comment Deadline HRSA published two Federal Register Notices (FRNs) about another potential 340B…

HRSA Seeks Information from Stakeholders on Another Potential 340B Rebate Model

2/17/2026 – HRSA Seeks Information from Stakeholders on Another Potential 340B Rebate Model HRSA has released a request for information (RFI) seeking input on a possible 340B rebate program. The RFI is…

In a Victory for Covered Entities, Fifth Circuit Upholds Louisiana’s 340B Contract Pharmacy Protection Law

2/11/2026 – In a Victory for Covered Entities, Fifth Circuit Upholds Louisiana’s 340B Contract Pharmacy Protection Law In a consolidated decision involving AbbVie, AstraZeneca, and the Pharmaceutical Research and Manufacturers of America…

HRSA Takes Steps to Pursue New 340B Rebate Model

2/11/2026 – HRSA Takes Steps to Pursue New 340B Rebate Model HRSA announced its intention to pursue a new 340B rebate model last week through submission of a “Prerule” regarding…

Trump’s Online Marketplace for Direct-to-Consumer Drugs is Now Live, and Could Impact 340B

2/10/2026 – Trump’s Online Marketplace for Direct-to-Consumer Drugs is Now Live, and Could Impact 340B Last week, HHS launched its website TrumpRx.gov which the Administration says is intended to “facilitate direct-to-consumer purchasing…

CMS Announces Drugs Subject to IRA Negotiated Prices Starting in 2028

1/30/2026 CMS Announces Drugs Subject to IRA Negotiated Prices Starting in 2028 Please click on the link below: CMS Announces Drugs Subject to IRA Negotiated Prices Starting in 2028 Powers…

Eli Lilly Announces Covered Entities Must Submit Claims Data for All of Its Products

1/16/2026 – Eli Lilly Announces Covered Entities Must Submit Claims Data for All of Its Products Pharmaceutical manufacturer Eli Lilly announced that, effective February 1, all covered entities must submit claims-level…

Response to 340B ACCESS Act Sign-on Letter

01/16/2025 – Response to 340B ACCESS Act Sign-on Letter Several patient and provider organizations sent a letter to the House Energy and Commerce committee in October 2025 supporting legislation opposed…